flashContent
Company news

07 September 2017

GC Alkor Bio together with Saint-Petersburg Pasteur Institute received patent "Method for identifying variants A and B of human herpesvirus type 6"

In August Group of Companies Alkor Bio and Saint-Petersburg Pasteur Institute received a patent "Method for identifying variants A and B of human herpesvirus type 6". The patent RU 2627607 was issued by Russian Federal Service for Intellectual Property (Rospatent). The invention relates to the field of biotechnology, in particular, to the clinical laboratory diagnosis of viral infections and can be used for genotyping of herpesvirus type 6 (HHV-6). Fast and reliable method for identification and differentiation of HHV-6A and HHV-6B types was claimed.

25 July 2017

Alkor Bio Group’s Microbiology laboratory has launched a new product: Toxoplasma gondii antigen (strain RH)

In July 2017, Alkor Bio Group’s Microbiology laboratory has launched a new product: Toxoplasma gondii antigen (strain RH).

18 May 2017

Alkor Bio Group has participated in CMEF 2017 in Shanghai

Alkor Bio Group, one of the Russian leading manufacturers of reagent kits for laboratory in vitro diagnostics, has participated in the 77th China International Medical Equipment Fair (CMEF Spring 2017) event was held May 15-18 in Shanghai.

All news
Science news
All articles

Group "Alcor Bio" was established in 2007 on the basis of "Alcor Bio, the national leader in the manufacture of diagnostic products based on enzyme immunoassay.

In 2002, the company Alkor Bio "was singled company" Trans-Technologies, which specializes in studying the biology of human stem cells. On the basis of experimental data specialists are developing new methods of treatment of various diseases using stem cells.

OOO "Diagnostic Centers Alkor Bio provides the population of St. Petersburg laboratory diagnostic services. Besides DC Alkor Bio "is a clinical testing ground for clinical validation of diagnostic products manufactured by Company Alkor Bio.